Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma

Authors

Patrick Grierson, Washington University School of Medicine in St. Louis
Andrea Teague, New Mexico Cancer Care Associates, Santa Fe
Rama Suresh, Washington University School of Medicine in St. Louis
Kian-Huat Lim, Washington University School of Medicine in St. Louis
Manik Amin, Washington University School of Medicine in St. Louis
Katrina Pedersen, Washington University School of Medicine in St. Louis
Benjamin Tan, Washington University School of Medicine in St. Louis
Jesse Huffman, Washington University School of Medicine in St. Louis
Nick Boice, Washington University School of Medicine in St. Louis
Lingling Du, Ochsner Health System, New Orleans
Jingxia Liu, Washington University School of Medicine in St. Louis
A. Craig Lockhart, University of Miami
Andrea Wang-Gillam, Washington University School of Medicine in St. Louis

Journal

Journal Gastrointestinal Oncology

Publication Date

2-1-2020

Volume

11

Issue

1

First Page

61

Last Page

67

Document Type

Open Access Publication

DOI

10.21037/jgo.2019.11.06

Rights and Permissions

Grierson P, Teague A, Suresh R, Lim KH, Amin M, Pedersen K, Tan B, Huffman J, Boice N, Du L, Liu J, Lockhart AC, Wang-Gillam A. Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma. J Gastrointest Oncol 2020;11(1):61-67. doi: 10.21037/jgo.2019.11.06

Recommended Citation

Grierson, Patrick; Teague, Andrea; Suresh, Rama; Lim, Kian-Huat; Amin, Manik; Pedersen, Katrina; Tan, Benjamin; Huffman, Jesse; Boice, Nick; Du, Lingling; Liu, Jingxia; Lockhart, A. Craig; and Wang-Gillam, Andrea, "Phase Ib/II study combining tosedostat with capecitabine in patients with advanced pancreatic adenocarcinoma." Journal Gastrointestinal Oncology. 11, 1. 61 - 67. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9919